Under construction – not a live service
Sign in
Taking people in FranceNo phase

Testing whether trained dogs can sniff out bladder cancer in urine samples

Tests whether trained sniffer dogs can detect bladder cancer from urine samples in adults.

Plain-language title generated from the registry record
Registry title: Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs

Key facts

Where
Colmar and Strasbourg, FranceSee the 2 sites

Where in France

  • Hôpitaux Civils de ColmarColmar, FranceTaking people
  • Hopitaux Universitaires de StrasbourgStrasbourg, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital, Strasbourg, France
Trial code
NCT07334314
Record updated
12 January 2026
Original description
The aim of this study is to estimate the sensitivity of olfactory detection of urothelial carcinomas of the bladder in urine samples by assistance dogs trained in this practice.Read full original descriptionShow less

Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs

The aim of this study is to estimate the sensitivity of olfactory detection of urothelial carcinomas of the bladder in urine samples by assistance dogs trained in this practice.

Inclusion: Adult (> 18 years old); Subject scheduled for any endourological surgery involving an initial cystoscopy, the most common of which are: transurethral resection of the bladder, transurethral resection of the prostate, internal optical urethrotomy, bladder lithoclast, ureteral stent replacement, ureteroscopy, etc. (non-exhaustive list); Subjects for whom a urine sample (for bacteriological or cytological testing) is planned as part of routine practice in the month prior to the procedure; Subjects affiliated with a health insurance plan or beneficiaries of such a plan.

Exclusion: History of cancer other than urothelial bladder carcinoma, unless in complete remission for > 5 years; Absence of signed informed consent / inability to provide the subject with informed information (emergency situations, difficulties in understanding the subject, etc.); Patient under guardianship, conservatorship, or judicial protection; Pregnant or breastfeeding women.

ClinicalTrials.gov NCT07334314